Here are the Discovery of Selenium-Containing Derivatives as Potent and Orally Bioavailable GLP-1R Agonists journals presenting the latest research across various disciplines. From social sciences to technology, each article is expected to provide valuable insights to our readers.
When was selenium developed, selenium in its natural form, discovery of witches cast, where was selenium found, when was selenium developed, how was selenium discovered, what is selenium named after, selenium study material pdf, discovery of witches books.
Discovery of Selenium-Containing Derivatives as Potent and Orally Bioavailable GLP-1R Agonists
Glucagon-like peptide-1 receptor (GLP-1R) is a well-established target for the treatment of type 2 diabetes mellitus (T2DM) and obesity. The development of orally bioavailable and long-acting small-molecule GLP-1R agonists is a pursuit in both academia and industry. Herein, new selenium (Se)-containing compounds were designed using a Se-oxygen bioisostere strategy on the danuglipron scaffold. Among these, compound 21 was orally bioavailable and exhibited full agonistic efficacy in promoting cyclic adenosine monophosphate (cAMP) accumulation. In hGLP-1R knock-in mice, 21 effectively reduced blood glucose levels and food intake, with the duration of action slightly extended compared to that of danuglipron. Importantly, no significant adverse effects were observed in mice treated with 21 during the subacute toxicity studies. This study delineates the potential of Se-containing compounds as orally bioavailable GLP-1R agonists, with compound 21 emerging as a promising candidate fo r T2DM and obesity treatment. © 2025 American Chemical Society.
Authors : Chen X.; Xu S.; Yang S.; Yu Z.; Chen Y.; Wu H.; Bao Q.; You Q.; Guo X.; Jiang Z.
Source : American Chemical Society
Article Information
| Year | 2025 |
| Type | Article |
| DOI | 10.1021/acs.jmedchem.4c02616 |
| ISSN | 00222623 |
| Volume |
You can download the article here
If You have any problem, contact us here